FIELD: chemistry.
SUBSTANCE: invention relates to a crystalline form of a compound having the formula (I), where R1 represents a hydrogen atom or a C 1-3 alkyl group, R2 represents a hydrogen atom or an oxo group, L represents a single bond or a C1-3 alkylene group, and X is CH or N, namely the compound with formula (I) is 1-(6-((6-((1R)-1-hydroxyethyl)-8-(isopropylamino)pyrido[3,4-d ]pyrimidine-2-yl)amino)-3-pyridyl)piperazin-2-one, wherein THE said crystalline form of the compound has peaks with diffraction angles of 2θ = 6.3°, 6.6°, 11.6°, 16.9° and 20.0° in the spectrum of powder X-ray diffraction or 2θ = 5.3°, 7.3°, 10.3°, 15.1° and 17.4° in the spectrum of powder X-ray diffraction; where the compound with formula (I) is 1-(6-((6-((1R)-1-methoxyethyl)-8-(isopropylamino)pyrido[3,4-d]pyrimidine-2-yl)amino)-3-pyridazyl)piperazine, where the indicated crystalline form of the compound has peaks with diffraction angle of 2θ = 5.2°, 7.6°, 8.4°, 10.5°, 15.2°, 16.9°, 20.1°, 21.0°, 23.3° and 26.6° in the spectrum of powder X-ray diffraction or 2θ = 5.2°, 6.6°, 8.1°, 15.2°, 15.9°, 16.2°, 18.8°, 20.5°, 20.8° and 21.7° in the spectrum of powder X-ray diffraction; where the compound with formula (I) is (R)-N8-isopropyl-6-(1-methoxyethyl)-N2-(5-(piperazin-1-ylmethyl)pyridin-2-yl)pyrido[3,4-d] pyrimidine-2,8-diamine, where the indicated crystalline form has peaks with diffraction angles of 2θ = 4.8°, 7.6°, 8.2°, 9.7°, 15.3°, 16.6°, 19.1°, 19.8°, 22.4° and 26.2° in the powder x-ray diffraction spectrum.
EFFECT: crystalline forms of pyrido[3,4-d]pyrimidine derivative having activity against cyclin-dependent kinase 4 and/or cyclin-dependent kinase 6 (CDK4/6).
22 cl, 28 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2016 |
|
RU2695337C2 |
MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED COCRYSTAL FORMERS | 2013 |
|
RU2650524C2 |
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE | 2011 |
|
RU2570198C2 |
SALT OF CONDENSED HETEROCYCLIC DERIVATIVE AND ITS CRYSTALS | 2011 |
|
RU2557237C2 |
COMPOUNDS SUITABLE FOR USE AS ATR KINASE INHIBITORS | 2014 |
|
RU2687276C2 |
ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH | 2020 |
|
RU2786588C1 |
PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
NOVEL CRYSTALLINE FORMS OF DIPEPTIDYLPEPTIDASE-IV INHIBITORS | 2012 |
|
RU2598072C2 |
ISETHIONATE SALT OF CDK4 SELECTIVE INHIBITOR | 2004 |
|
RU2317296C2 |
SOLID FORMS OF SELECTIVE CDK4/6 INHIBITOR | 2014 |
|
RU2619944C2 |
Authors
Dates
2023-04-05—Published
2017-11-27—Filed